Poor trading in the US has helped push the FTSE 100 index below the 4,800 level.
The UK benchmark has slipped for a third day, down about 25 points to 4,793, paced by SABMiller. The brewer has shed 19p to 811.50p after reports that it is the lead candidate to take control of Colombian competitor Grupo Empresarial Bavaria. Royal & Sun Alliance Insurance has lost 1.75p to 84.50p. Reuters is down 8.50p to 388.75p. GlaxoSmithKline is down 7p to 1,181p after a European court ruled one of its big sellers, and anti-depressant, will no longer enjoy protection against generic rivals. Shire Pharmaceuticals meanwhile has added 3.50p to 622p. In the US, the Dow Jones...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
